Nikko Asset Management Americas Lowers stake in Monsanto Company (MON)

Monsanto Company (MON) : Nikko Asset Management Americas reduced its stake in Monsanto Company by 15.5% during the most recent quarter end. The investment management company now holds a total of 226,300 shares of Monsanto Company which is valued at $22,616,422 after selling 41,500 shares in Monsanto Company , the firm said in a disclosure report filed with the SEC on May 10, 2016.Monsanto Company makes up approximately 2.61% of Nikko Asset Management Americas’s portfolio.

Other Hedge Funds, Including , Beacon Investment Advisory Services reduced its stake in MON by selling 70 shares or 1.84% in the most recent quarter. The Hedge Fund company now holds 3,725 shares of MON which is valued at $372,277. Monsanto Company makes up approx 0.16% of Beacon Investment Advisory Services’s portfolio.Trust Investment Advisors reduced its stake in MON by selling 70 shares or 1.39% in the most recent quarter. The Hedge Fund company now holds 4,970 shares of MON which is valued at $446,058. Monsanto Company makes up approx 0.51% of Trust Investment Advisors’s portfolio.Aperio Group reduced its stake in MON by selling 1,409 shares or 1.03% in the most recent quarter. The Hedge Fund company now holds 135,757 shares of MON which is valued at $12,717,716. Monsanto Company makes up approx 0.11% of Aperio Group’s portfolio. New Jersey Better Educational Savings Trust added MON to its portfolio by purchasing 5,000 company shares during the most recent quarter which is valued at $468,400. Monsanto Company makes up approx 0.32% of New Jersey Better Educational Savings Trust’s portfolio.

Monsanto Company closed down -1.66 points or -1.66% at $98.28 with 26,47,699 shares getting traded on Monday. Post opening the session at $99.39, the shares hit an intraday low of $97.98 and an intraday high of $99.63 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Monsanto Company reported $2.42 EPS for the quarter, based on the information available during the earnings call on Apr 6, 2016. Analyst had a consensus estimate of $2.42. The company had revenue of $4532.00 million for the quarter, compared to analysts expectations of $4734.36 million. The company’s revenue was down -12.8 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $2.90 EPS.

Many Wall Street Analysts have commented on Monsanto Company. Shares were Reiterated by Deutsche Bank on Apr 7, 2016 to “Buy” and Lowered the Price Target to $ 100 from a previous price target of $105 .Monsanto Company was Downgraded by Citigroup to ” Neutral” on Mar 14, 2016. Monsanto Company was Downgraded by Goldman to ” Sell” on Mar 4, 2016.

Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds biotechnology trait products and herbicides provide farmers with solutions that improve productivity reduce the costs of farming and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics and Agricultural Productivity. Through its Seeds and Genomics segment it produces seed brands including DEKALB Asgrow Deltapine Seminis and De Ruiter and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Leave a Reply

Monsanto Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Monsanto Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.